Amplification of S6K1 (p70S6K1, ribosomal protein S6KB1) and elevated levels of phosphorylated S6K1 are considered biomarkers of aggressive breast cancer (BCa) that are resistant to neoadjuvant chemotherapy (Kim EK. This evidence concerns the gene RPS6KB1 and breast carcinoma.